Učitavanje...

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93

With over eight million cases of tuberculosis each year there is a pressing need for the development of new vaccines against Mycobacterium tuberculosis. Subunit vaccines consisting of recombinant proteins are an attractive vaccine approach due to their inherent safety compared to attenuated live vac...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Orr, Mark T., Beebe, Elyse A., Hudson, Thomas E., Moon, James J., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880254/
https://ncbi.nlm.nih.gov/pubmed/24404140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0083884
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!